IR
57
2
STZ
50
7
ADI
47
-2
MAS
58
2
NSC
47
-3
LB
30
-8
PNC
52
-3
ES
48
-2
LEG
28
6
NWL
54
-2
PRGO
39
-4
RF
53
-3
CINF
37
6
APD
47
-2
KEY
33
-4
WEC
41
-4
OKE
65
4
COST
50
2
GLW
48
-4
LUV
39
-5
IR
57
2
STZ
50
7
ADI
47
-2
MAS
58
2
NSC
47
-3
LB
30
-8
PNC
52
-3
ES
48
-2
LEG
28
6
NWL
54
-2
PRGO
39
-4
RF
53
-3
CINF
37
6
APD
47
-2
KEY
33
-4
WEC
41
-4
OKE
65
4
COST
50
2
GLW
48
-4
LUV
39
-5
Financhill
Back

GlycoMimetics 10K Form

Buy
73

GLYC
GlycoMimetics

Last Price:
0.41
Seasonality Move:
59.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q GLYC/GlycoMimetics Quarterly
2023-11-03 10Q GLYC/GlycoMimetics Quarterly
2023-08-02 10Q GLYC/GlycoMimetics Quarterly
2023-05-03 10Q GLYC/GlycoMimetics Quarterly
2022-11-09 10Q GLYC/GlycoMimetics Quarterly
2022-08-03 10Q GLYC/GlycoMimetics Quarterly

Receive GLYC News And Ratings

See the #1 stock for the next 7 days that we like better than GLYC

GLYC Financial Statistics

Sales & Book Value

Annual Sales: $10K
Cash Flow: $-8.9M
Price / Cash Flow: 0
Annual Sales: $0.31
Price / Book: 1.32

Profitability

EPS (TTM): -0.61000
Net Income (TTM): $-39.11M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

GlycoMimetics Earnings Forecast

Key GlycoMimetics Financial Ratios

  • The Gross Profit Margin over the past 4 years for GLYC is 0.00%.
  • The Selling, General & Administrative Expenses for GLYC have been equal to 192,130.00% of Gross Profit Margin.
  • The Research & Development expenses have been 200,716.60% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of GLYC is -368,994.20% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

GlycoMimetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GLYC
CUSIP: 38000Q
Website: glycomimetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GLYC Technical Analysis vs Fundamental Analysis

Buy
73
GlycoMimetics (GLYC) is a Buy

Is GlycoMimetics a Buy or a Sell?

  • GlycoMimetics stock is rated a Buy
    The current GlycoMimetics [GLYC] share price is $0.41. The Score for GLYC is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.